Work

IL4/IL13 Inhibition via Dupilumab Reduces Malignant T-cell Proliferation and Promotes Antitumor Immunity in Sézary Syndrome

Year: 2025

Type: article

Source: Cancer Immunology Research

DOI: 10.1158/2326-6066.cir-25-0677

Authors: Larisa J. Geskin, Alyxzandria M. Gaydosik, Brigit Lapolla, Patrizia Fuschiotti

Institutions: Columbia University Irving Medical Center, Columbia University, University of Pittsburgh

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Regeneron Pharmaceuticals

Award: G675512444

OpenAlex ID: W4415667058

FWCI: 1.642

Cites: 71

Cited by: 2

Related to: